Moneycontrol PRO
HomeNewsBhel
Jump to
  • BHEL to develop fuel cell-based trains in partnership with Singapore-based Horizon Tech

    BHEL to develop fuel cell-based trains in partnership with Singapore-based Horizon Tech

    A hydrogen fuel cell-based rolling stock uses on-board hydrogen fuel cells to generate electricity, and is a zero-emission alternative to diesel or electric trains.

  • Hold BHEL; target of Rs 215: Prabhudas Lilladher

    Hold BHEL; target of Rs 215: Prabhudas Lilladher

    Prabhudas Lilladher recommended hold rating on BHEL with a target price of Rs 215 in its research report dated August 07, 2025.

  • BHEL Standalone June 2025 Net Sales at Rs 5,486.91 crore, up 0.04% Y-o-Y

    BHEL Standalone June 2025 Net Sales at Rs 5,486.91 crore, up 0.04% Y-o-Y

  • BHEL shares fall over 6 percent as CLSA recommends 'Underperform' after net loss doubles

    BHEL shares fall over 6 percent as CLSA recommends 'Underperform' after net loss doubles

    Bharat Heavy Electricals (BHEL) said its net loss more than doubled to Rs 455.50 crore in the June quarter mainly due to higher expenses, compared to a net loss of Rs 211.40 crore a year ago.

  • UBS initiates coverage on BHEL, Waaree, Suzlon, Premier Energies; sees up to 40% upside

    UBS initiates coverage on BHEL, Waaree, Suzlon, Premier Energies; sees up to 40% upside

    UBS kicked off coverage with a ‘buy’ rating on power generation players BHEL, Waaree Energies, Premier Energies, and Suzlon Energy.

  • BHEL shares jump 3% to hit 6-month high after firm wins Rs 6,500-crore order from Adani Power

    BHEL shares jump 3% to hit 6-month high after firm wins Rs 6,500-crore order from Adani Power

    BHEL share price: BHEL shares opened at Rs 272 apiece, the highest level seen by the stock in nearly 6 months.

  • Stocks to Watch Today: Torrent Pharma, JB Chemicals, Jyoti CNC, BHEL, Alembic Pharma, Waaree Energies, Prestige Estates, Hind Rectifiers in focus on 30 June

    Stocks to Watch Today: Torrent Pharma, JB Chemicals, Jyoti CNC, BHEL, Alembic Pharma, Waaree Energies, Prestige Estates, Hind Rectifiers in focus on 30 June

    Stocks to Watch, 30 June: Stocks like Torrent Pharmaceuticals, JB Chemicals and Pharmaceuticals, Jyoti CNC Automation, BHEL, Alembic Pharma, Waaree Energies, Prestige Estates Projects, Bharti Airtel, Le Lavoir, Reliance Industries, and Hind Rectifiers will be in focus on June 30.

  • Smallcap, midcap stocks rise up to 15%, broader market indices extend gains for second day; check top gainers

    Smallcap, midcap stocks rise up to 15%, broader market indices extend gains for second day; check top gainers

    BEML shares were the top gainer on the smallcap index, rallying over 15 percent to close at Rs 4,294.60 apiece.

  • Hold BHEL; target of Rs 237: Prabhudas Lilladher

    Hold BHEL; target of Rs 237: Prabhudas Lilladher

    Prabhudas Lilladher recommended hold rating on BHEL with a target price of Rs 237 in its research report dated May 20, 2025.

  • Chart of the Day: BHEL’s record order book faces a moment of reckoning

    Chart of the Day: BHEL’s record order book faces a moment of reckoning

    The company saw record order inflows for second consecutive year in FY25

  • BHEL Consolidated March 2025 Net Sales at Rs 8,993.37 crore, up 8.88% Y-o-Y

    BHEL Consolidated March 2025 Net Sales at Rs 8,993.37 crore, up 8.88% Y-o-Y

  • BHEL Standalone March 2025 Net Sales at Rs 8,993.37 crore, up 8.88% Y-o-Y

    BHEL Standalone March 2025 Net Sales at Rs 8,993.37 crore, up 8.88% Y-o-Y

  • BHEL Q4 results: Net profit rises 4% to Rs 504 crore, firm declares dividend

    BHEL Q4 results: Net profit rises 4% to Rs 504 crore, firm declares dividend

    BHEL Q4 results: Revenue jumps 9% to Rs 8,993 crore

  • Defence stocks gain on escalating India-Pakistan tension; Paras Defence, Zen Technologies soar up to 6%

    Defence stocks gain on escalating India-Pakistan tension; Paras Defence, Zen Technologies soar up to 6%

    On May 8, shares of defence companies tumbled in the second half amidst profit booking with most defence players losing early gains.

  • BHEL shares slip 5% after Ducon Tech initiates arbitration against firm

    BHEL shares slip 5% after Ducon Tech initiates arbitration against firm

  • Stocks To Watch: Alembic Pharma, BHEL, Zydus Life, Wipro In Focus | February 17

    Stocks To Watch: Alembic Pharma, BHEL, Zydus Life, Wipro In Focus | February 17

    In today's stock market update for February 17, we highlight key stocks to watch: Wipro, which appointed Amit Kumar as Managing Partner and Global Head of Consulting; BHEL, which secured a Letter of Intent for a thermal power project; and Alembic Pharma, which received a Voluntary Action Indicated classification from the US FDA for its Jarod facility. Zydus Lifesciences passed a successful US FDA inspection with no observations at its Ambernath site. Meanwhile, Ujjivan Small Finance Bank and Shriram Finance face RBI penalties for non-compliance with loan and KYC regulations. Stay tuned for more market insights!

  • BHEL wins Rs 6,200-crore order from Damodar Valley Corp

    BHEL wins Rs 6,200-crore order from Damodar Valley Corp

    The order is for Steam Generator Island Package of 2x660 MW Raghunathpur Thermal Power Station Phase-II project at West Bengal's Purulia district, said BHEL

  • Accumulate BHEL; target of Rs 226: Prabhudas Lilladher

    Accumulate BHEL; target of Rs 226: Prabhudas Lilladher

    Prabhudas Lilladher recommended accumulate rating on BHEL with a target price of Rs 226 in its research report dated January 29, 2025.

  • BHEL Consolidated December 2024 Net Sales at Rs 7,277.09 crore, up 32.22% Y-o-Y

    BHEL Consolidated December 2024 Net Sales at Rs 7,277.09 crore, up 32.22% Y-o-Y

  • BHEL Standalone December 2024 Net Sales at Rs 7,277.09 crore, up 32.22% Y-o-Y

    BHEL Standalone December 2024 Net Sales at Rs 7,277.09 crore, up 32.22% Y-o-Y

  • BHEL Q3 results: Firm doubles net profit to Rs 135 crore, revenue rises 32%

    BHEL Q3 results: Firm doubles net profit to Rs 135 crore, revenue rises 32%

    The government’s renewed focus on setting up thermal power projects and a surge in demand for coal-fuelled power generation have revived the fortunes of BHEL the country's largest power equipment manufacturer.

  • Trade Spotlight: How should you trade Hindustan Unilever, Sun Pharma, Siemens, Jubilant FoodWorks, Biocon, BHEL, and others on January 14?

    Trade Spotlight: How should you trade Hindustan Unilever, Sun Pharma, Siemens, Jubilant FoodWorks, Biocon, BHEL, and others on January 14?

    The market may attempt a rebound amid likely consolidation; however, the overall sentiment remains bearish. Below are some trading ideas for the near term.

  • Strong indigenisation push spur optimism for defence cos despite valuation concerns

    Strong indigenisation push spur optimism for defence cos despite valuation concerns

    Nuvama forecasts significant growth for the defence sector, forecasting $130 billion in spending for the sector over the next five years.

  • BHEL, Hitachi Energy India stocks rally up to 8% on securing Khavda-Nagpur renewable energy project

    BHEL, Hitachi Energy India stocks rally up to 8% on securing Khavda-Nagpur renewable energy project

    Nuvama Institutional Equities expects Hitachi Energy India's share of the order inflow to be around Rs 4,000-6,000 crore.

  • L&T well positioned to win 4 GW orders from NTPC in Q3, says management

    L&T well positioned to win 4 GW orders from NTPC in Q3, says management

    As part of the tenders floated by NTPC, the company that has emerged as lowest bidder for the three project would be offered to complete two projects while the second-lowest bidder would be offered to complete the third project at the price bid by the lowest bidder

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347